Adapting international clinical trials during COVID-19 and beyond
Journal article
Thriemer K. et al, (2023), Clinical Trials, 174077452311542 - 174077452311542
Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial
Journal article
Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90
Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries
Journal article
Srisutham S. et al, (2022), PLOS ONE, 17, e0278928 - e0278928
Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning
Journal article
Das D. et al, (2022), Malaria Journal, 21
Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia
Journal article
Adhikari B. et al, (2022), Malaria Journal, 21
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
Journal article
van der Pluijm RW. et al, (2022), The Lancet Infectious Diseases, 22, 765 - 766
Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial
Journal article
Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878
Optimizing bulk segregant analysis of drug resistance using Plasmodium falciparum genetic crosses conducted in humanized mice
Journal article
Brenneman KV. et al, (2022), iScience, 25, 104095 - 104095
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
Journal article
Zhu L. et al, (2022), Communications Biology, 5
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Journal article
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
Assessment In Vitro of the Antimalarial and Transmission-Blocking Activities of Cipargamin and Ganaplacide in Artemisinin-Resistant Plasmodium falciparum.
Journal article
Yipsirimetee A. et al, (2022), Antimicrobial agents and chemotherapy, 66
Acceptability and feasibility of malaria prophylaxis for forest goers: findings from a qualitative study in Cambodia
Journal article
Jongdeepaisal M. et al, (2021), Malaria Journal, 20
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
Journal article
Mukaka M. et al, (2021), Malaria Journal, 20
Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion
Journal article
Imwong M. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination
Journal article
Jacob CG. et al, (2021), eLife, 10
Study protocol: an open-label individually randomised controlled trial to assess the efficacy of artemether-lumefantrine prophylaxis for malaria among forest goers in Cambodia
Journal article
Maude RJ. et al, (2021), BMJ Open, 11, e045900 - e045900
Theory of change: Drama and arts-based community engagement for malaria research and elimination in Cambodia
Journal article
Ean M. et al, (2021), Wellcome Open Research, 6, 46 - 46
Development of Weight and Age-based Dosing of Daily Primaquine for Radical Cure of Vivax Malaria
Journal article
Taylor WR. et al, (2021)
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Journal article
Chandna A. et al, (2021), Wellcome Open Research, 6, 64 - 64
Theory of change: Drama and arts-based community engagement for malaria research and elimination in Cambodia
Journal article
Ean M. et al, (2021), Wellcome Open Research, 6, 46 - 46